论文部分内容阅读
目的:分析HP阳性胃炎的临床治疗使用依卡倍特钠的具体效果。方法:随机选取我院2013年10月~2014年6月入院接受治疗的100例HP阳性胃炎患者,随机将其分成治疗组与观察组两组,观察组使用奥美拉唑、克拉霉素和甲硝唑治疗,治疗组在观察组的治疗基础上联用依卡倍特钠。所有患者服药时间在早晚餐后半小时。结果:治疗组有效率为94%,观察组的治疗有效率为72%,治疗组治疗效果明显优于观察组(P<0.05),两组差异具有统计学意义。结论:临床治疗HP阳性胃炎,使用依卡倍特钠效果突出,临床治疗过程中可优先选择。
Objective: To analyze the clinical effect of using eclampsia in the treatment of HP-positive gastritis. Methods: A total of 100 patients with HP-positive gastritis admitted to our hospital from October 2013 to June 2014 were randomly divided into two groups: treatment group and observation group. Omeprazole, clarithromycin and Metronidazole treatment, the treatment group in the observation group based on the treatment of combined with ibacate sodium. All patients took half an hour after breakfast and dinner. Results: The effective rate was 94% in the treatment group and 72% in the observation group. The treatment effect in the treatment group was significantly better than that in the observation group (P <0.05). The difference between the two groups was statistically significant. Conclusion: The clinical treatment of HP-positive gastritis, the use of intracavity sodium prominent effect, the clinical course of treatment may be preferred.